During the past decade, Maine Hemophilia and Thrombosis Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maine Hemophilia and Thrombosis Center" #1 collaborator was "CSL Behring" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "American Thrombosis and Hemostasis Network" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "BioMarin Pharmaceutical" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Maine Hemophilia and Thrombosis Center" are "Hemophilia" (3 trials), "Hemophilia A With Inhibitor" (3 trials), "Hemophilia B With Inhibitor" (3 trials), "Haemophilia A Without Inhibitor" (2 trials) and "Haemophilia B Without Inhibitor" (2 trials). Many other conditions were trialed in "Maine Hemophilia and Thrombosis Center" in a lesser frequency.

Most popular intervention types in "Maine Hemophilia and Thrombosis Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013" (1 trials), "Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013" (1 trials), "New FVIII products" (1 trials) and "coagulation factor VIIa [recombinant]-jncw" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maine Hemophilia and Thrombosis Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Maine Hemophilia and Thrombosis Center". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Maine Hemophilia and Thrombosis Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Maine Hemophilia and Thrombosis Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".